Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Rodey

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Human Immunology|August 1, 1997
HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedureT C Fuller, A A Fuller, M Golden, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1976
Measurement of the fractional uptake of macromolecules by the renal vascular bed compared to other vascular bedsL A Hebert, K A Stuart, C Allhiser, et al.
Human Immunology|December 1, 1980
HLA serological cross-reactivity: HLA-B15 has two public antigensB D Schwartz, L K Luehrman, T Lee, et al.
Circulation|July 1, 1981
Mitral valve prolapse: a consistent manifestation of type IV Ehlers-Danlos syndrome. The pathogenetic role of the abnormal production of type III collagenA S Jaffe, E M Geltman, G E Rodey, et al.
Arthritis and Rheumatism|November 1, 1980
Association of HLA-DRw4 with rheumatoid arthritis in black and white patientsR W Karr, G E Rodey, T Lee, et al.
Human Immunology|July 1, 1990
Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probesA A Fuller, G E Rodey, P Parham, et al.
Transplantation|April 15, 1996
In support of the findings of Christopher F. Bryan et alT C Fuller, A Fuller, J M McCormack, et al.
Transplantation|July 1, 1982
Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity testT C Fuller, D Phelan, H M Gebel, et al.
Blood|February 1, 1976
A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief reportJ T Casper, S Koethe, G E Rodey, et al.
Human Immunology|July 1, 1980
A public antigenic determinant in the HLA-B5 cross-reacting group--a basis for cross-reactivity and a possible link with Behcet's diseaseB D Schwartz, L K Luehrman, J Lee, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Human Immunology|August 1, 1997
HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedureT C Fuller, A A Fuller, M Golden, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1976
Measurement of the fractional uptake of macromolecules by the renal vascular bed compared to other vascular bedsL A Hebert, K A Stuart, C Allhiser, et al.
Human Immunology|December 1, 1980
HLA serological cross-reactivity: HLA-B15 has two public antigensB D Schwartz, L K Luehrman, T Lee, et al.
Circulation|July 1, 1981
Mitral valve prolapse: a consistent manifestation of type IV Ehlers-Danlos syndrome. The pathogenetic role of the abnormal production of type III collagenA S Jaffe, E M Geltman, G E Rodey, et al.
Arthritis and Rheumatism|November 1, 1980
Association of HLA-DRw4 with rheumatoid arthritis in black and white patientsR W Karr, G E Rodey, T Lee, et al.
Human Immunology|July 1, 1990
Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probesA A Fuller, G E Rodey, P Parham, et al.
Transplantation|April 15, 1996
In support of the findings of Christopher F. Bryan et alT C Fuller, A Fuller, J M McCormack, et al.
Transplantation|July 1, 1982
Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity testT C Fuller, D Phelan, H M Gebel, et al.
Blood|February 1, 1976
A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief reportJ T Casper, S Koethe, G E Rodey, et al.
Human Immunology|July 1, 1980
A public antigenic determinant in the HLA-B5 cross-reacting group--a basis for cross-reactivity and a possible link with Behcet's diseaseB D Schwartz, L K Luehrman, J Lee, et al.
Pageof 9